Clinical Trial Update: Micafungin Lock Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating micafungin lock therapy for catheter-related fungal infections has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Fungal Infections

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Catheter-Related Fungal Infections | Phase 1 | Status: TERMINATED